Volume 18 - Issue 8 - August 2005
Many of my colleagues have voiced concerns regarding the use of nutriceuticals in their practices. The expressed concerns range from “These things are unproven” and “There is no FDA scrutiny over these products” to “They don’t work all the time” and “There are no scientific, double-blind, placebo-controlled studies on their safety or effectiveness.”
I had many of the same doubts before I incorporated nutriceuticals into my practice over 12 years ago. Since my training in podiatry school was allopathic in nature, it was difficult for me t
New technologies abound and there is certainly no shortage of new innovations. There are new medications for diabetic neuropathic pain and antibiotic-resistant infections. There are innovative matrices that may enhance the healing environment for wounds. There are leading advances in the limb salvage arena as well as impressive modalities for facilitating bone healing. With that said, let us take a closer look at several new and emerging innovations that may prove beneficial to podiatrists and their patients.
1. Tigecycline (Tygacil™, Wye
Editor's Perspective »
What has always struck me about the podiatry profession is the diverse array of niches within the field. Podiatrists may specialize in the sports medicine arena or excel in ensuring appropriate wound care for high-risk patients with diabetes. Podiatric doctors may be known for their stellar surgical expertise while other DPMs have a strong knowledge of podiatric dermatology.
Addressing the diversity of the podiatric experience is a challenge that we look forward to with each issue. Nowhere is this diversity more apparent than in this month's edition, one
Diabetes Watch »
As we evolve in our treatment of foot and ankle conditions, it seems like each treatment meets with some reservation from the medical community. As podiatric physicians, our mindset is scientific in nature and we need hard facts and evidence-based results to show each treatment option is beneficial. I am with the mainstream in that thinking but I also try to rationalize a treatment option and see why it may or may not benefit a patient.
To that extent, there has been a great deal of interest in treatment options for diabetic neuropathy. A. Lee Dellon, MD
I wrote about cooking a few months ago in this column (see page 98, April issue). Since that column was published, many readers have called or written to ask for my recipe for salmon marinated in single malt Scotch and grilled on a cedar plank. I have a confession. I don’t usually use recipes when I cook.
Cooking is something I can experiment with and goof up without dire consequences so I wing it and no dish ever comes out the same twice. I will try to remember the basics of the marinated salmon and give you a usable recipe (see “Dr. McCord’s Recip
New Products »
Disguising Bumps And Bruises
Summer activity can bring bumps and bruises for children, and a new scar product can help DPMs improve the appearance of kids’ scars.
The new Mederma® for Kids™ is formulated for children between the ages of 2 and 12, and can minimize the appearance of scars resulting from injury, burns, bug bites and surgery, according to manufacturer Merz Pharmaceuticals. The company says the product is also perfect for scars from childhood diseases and stretch marks from weight fluctuation.
- « Previous
- | Page 1 of 3 |
- Next »